Values are given as mean ± S.D. *P<0.05; comparison within different genotypes was performed using one way Kruskal-Wallis, and then using Bonferroni post-hoc test. Group 1: type 2 diabetes without nephropathy, Group 2: type 2 diabetes with nephropathy.

Figure 2: Percent change in UAE, serum creatinine and eGFR after 36 months of ARB therapy among the three genotypes, stratified by the presence or absence of nephropathy, based on ACEI/D genotypes.